Search for: "Wyeth, also known as Wyeth, Inc."
Results 101 - 120
of 169
Sort by Relevance
|
Sort by Date
27 Jan 2011, 5:00 am
We know now – even if we don’t like it – after Wyeth v. [read post]
23 Dec 2010, 12:27 pm
Exxon Corp. and Exxon Texas, Inc. v. [read post]
22 Dec 2010, 12:39 pm
Centocor, Inc. v. [read post]
19 Dec 2010, 10:08 pm
The problem with that logic is that Wyeth, the makers of Reglan, also is being sued for not properly adding warnings to its labels. [read post]
10 Dec 2010, 2:23 pm
(Michigan Bell is also known as AT&T Michigan.) [read post]
21 Nov 2010, 5:56 pm
Genentech, Inc., No. 4:10CV1793-JCH (E.D. [read post]
11 Nov 2010, 12:54 pm
Wyeth, Inc., 2006 WL 2883030, at *4 (W.D. [read post]
8 Nov 2010, 5:00 am
According to his concurring opinion in Wyeth v. [read post]
8 Nov 2010, 4:30 am
Wyeth, Inc., 561 F.3d 233 (3rd Cir. 2009) (see the Third Circuit Court of Appeals' order here, from which Plaintiffs appealed). [read post]
18 Oct 2010, 12:05 pm
Wyeth Laboratories, Inc. doctrine did not apply.Congrats to our friends on the defense side, including Joe Hollingsworth and his firm. [read post]
12 Oct 2010, 7:37 am
The petition to the Supreme Court was Wyeth LLC, et al., v. [read post]
2 Oct 2010, 8:43 am
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
27 Aug 2010, 2:41 pm
Wyeth:[Plaintiff] also maintains that her alleged her causes of action, including her claims for “unreasonable marketing” and “negligent failure to withdraw,” are sustainable because they are akin to a failure to inspect and/or test claim. [read post]
4 Aug 2010, 3:46 pm
Wyeth, Inc., ___ A.2d ___, No. 2838 EDA 2008, slip op. [read post]
30 Jul 2010, 5:00 am
Wyeth, Inc., ___ A.2d ___, No. 2838 EDA 2008, slip op. [read post]
29 Jun 2010, 6:09 am
All patients in the study were given standard chemotherapy drugs while some patients were also treated with Mylotarg.The FDA also said at the time of its approval that Mylotarg was associated with a serious liver condition called veno-occlusive disease, the rate of which has increased in the postmarket setting.Pfizer said a measure known as the fatal induction toxicity rate, or the death rate during initial treatment, showed it was significantly higher among patients… [read post]
16 Jun 2010, 4:57 am
Ford Dodge Animal Health Inc. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
6 May 2010, 9:43 am
Wyeth, Inc., 601 F.Supp.2d 1262 (W.D.Okla. 2009), which was decided 5 days before Stacel. [read post]
21 Apr 2010, 12:08 pm
Wyeth Inc., 2008 WL 2856146 (N.J. [read post]
